Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of FLUAD 2010-2011 influenza vaccine in elderly subjects
2010-018603-29Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Fluzone Trivalent in influenza, sponsored by Novartis. Primary endpoints: Antibody response by SRH at Day 21, Seroconversion or significant increase rate and 3 more. Started Apr 2010; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2010-018603-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018603-29.